Artificial intelligence (AI) and machine learning (ML) are often heralded as game-changers in the advanced therapies space—but where are we really in terms of adoption and impact?

In this webinar, industry leaders cut through the noise to explore the current and practical use of AI/ML in cell and gene therapy development. From identifying what data needs to be captured to enable operational AI/ML pipelines, to examining live use cases already demonstrating value, this session offers a realistic picture of AI’s evolving role in the sector.